Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

14.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.1K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.5K
3.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.1K
3.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

27.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
27.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A U1-U3 snRNA-snoRNA interaction couples SF3B1 mutation to chromatin-state rewiring and genome instability.

bioRxiv : the preprint server for biology·2026
Same author

Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicing.

Leukemia·2026
Same author

An Isoform-Specific RUNX1C-BTG2 Axis Governs AML Quiescence and Chemoresistance.

Blood cancer discovery·2025
Same author

Chorionic Gonadotropin Beta 7 is a marker of immune evasion in cancer.

bioRxiv : the preprint server for biology·2025
Same author

Muscleblind-like proteins are novel modulators of the tumor-immune microenvironment.

PloS one·2025
Same author

Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias.

Cell·2025

Related Experiment Video

Updated: Apr 8, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K

Widespread intron retention diversifies most cancer transcriptomes.

Heidi Dvinge1, Robert K Bradley1

  • 1Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA USA ; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA USA.

Genome Medicine
|June 27, 2015
PubMed
Summary

Abnormal RNA splicing, marked by intron retention, is prevalent in most cancers, even without direct mutations to splicing machinery. This suggests intron-containing messenger RNAs (mRNAs) contribute to cancer

More Related Videos

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.5K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K

Related Experiment Videos

Last Updated: Apr 8, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.5K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Somatic mutations in RNA splicing machinery are frequent in many cancers, altering splice site recognition and potentially driving tumorigenesis.
  • These mutations can lead to distinct changes in how cells recognize splice sites and exons.

Purpose of the Study:

  • To investigate genome-wide RNA splicing patterns in matched tumor and normal samples across various cancer types.
  • To identify aberrant splicing signals associated with cancer development.

Main Methods:

  • Analysis of genome-wide RNA splicing patterns.
  • Comparison of 805 matched tumor and normal control samples from 16 distinct cancer types.

Main Results:

  • Widespread intron retention, a form of abnormal RNA splicing, is common across most cancers, irrespective of direct mutations in splicing machinery.
  • Breast cancer was an exception, showing intron retention in normal tissue rather than tumors.
  • Specific introns were preferentially retained in different cancer types, with some common across diverse cancers, particularly those involving splicing and export factors.
  • Intron retention levels correlated with IDH1/IDH2 mutations in acute myeloid leukemia and molecular subtypes in breast cancer.
  • Introns preferentially retained in primary cancers were found at high levels in cancer cell line cytoplasmic mRNA.

Conclusions:

  • Abnormal RNA splicing is a frequent feature of many cancers, even without direct mutational damage to the splicing machinery.
  • Intron-containing messenger RNAs (mRNAs) likely contribute to the transcriptional diversity observed in numerous cancers.